Longevity and the "Window of Opportunity"
BHRT in 2026 is increasingly viewed through the lens of Preventative Geriatrics, focusing on "Healthspan" rather than just symptom relief.
Bone Density: Estrogen therapy has been shown to decrease hip fracture risk by 33% and increase overall bone mineral density, addressing the 20% loss many women face immediately after menopause.
Neuroprotection: New 2026 studies suggest that bioidentical estradiol plays a critical neuroprotective role, enhancing communication between brain cells and reducing the "brain fog" that precedes cognitive decline.
Metabolic Health: BHRT is now used to help balance insulin and cortisol, aiding in the management of "menopausal weight gain" and reducing the risk of Type 2 Diabetes in postmenopausal women.
14 visualizzazioni
_edited.png)
